It’s not enough to give patients a voice. We need to give them a vote.
Every year, millions of dollars are poured into clinical trials and medical guideline development—but too often, those efforts leave out the very people they’re supposed to serve. Patient engagement is treated as an afterthought. A nice-to-have. A single checkbox.
We can—and must—do better.
The truth is, we already know what better looks like. Research like the IMMPACT recommendations laid the foundation. Now it’s time to finish the job.
This article outlines what we need to do—and how we do it—to embed meaningful, equitable, and lasting patient engagement in both clinical trials and guideline development panels. Whether you’re a researcher, clinician, policymaker, or advocate with lived experience, this is your call to action.
💡 What IMMPACT Taught Us—and Where We Fell Short
The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) was a milestone in centering the patient perspective in pain research. It helped standardize outcomes that mattered to people living with pain. But it didn’t fully answer: How do we sustain patient engagement across the entire research and policy process—start to finish?
Even today, we see:
- Patients brought in too late to influence study design or guideline scope.
- No real training or support for PWLE or researchers to work together.
- A lack of feedback on how input was used—or if it was used at all.
- Minimal dissemination of results back to the communities most impacted.
And even when engagement happens, one question still haunts us:
Why don’t the people who helped shape the research ever hear about the results?
📣 The Dissemination Gap: When Results Don’t Reach the People Who Need Them
Research results and guideline updates often:
- Stay locked behind paywalls or jargon-heavy publications.
- Bypass the communities that made them possible.
- Aren’t translated into formats accessible to people with disabilities or non-English speakers.
- Never show up in the spaces where patients actually gather—support groups, social media, or advocacy networks.
This is more than a missed opportunity. It’s a betrayal of trust.
To fix this, dissemination must be co-designed with PWLE, planned from the start, and resourced just like recruitment or data collection.
🔧 What We Should Do: A Real Framework for Patient Engagement
Let’s go from principles to practice. Here’s how.
👩‍⚕️ In Clinical Trials
Planning Phase:
- Embed PWLE advisors as co-applicants on grant proposals.
- Budget for ongoing engagement, not one-time panels.
- Host early co-design workshops before protocols are finalized.
Execution Phase:
- Place PWLE on DSMBs and ethics committees.
- Co-create participant-facing materials—consent forms, FAQs, check-ins.
- Assign a patient engagement coordinator to support communication throughout the trial.
Analysis & Dissemination:
- Include PWLE in data interpretation—especially for unexpected findings.
- Collaborate on plain-language summaries, audio/podcast explainers, or video walkthroughs.
- Fund community-based events to share findings with patient groups, support circles, and local organizations.
đź“Ś Real Example:
The UCSF REACH study on chronic low back pain included PWLEs in the analysis phase, helping interpret personal pain narratives using AI. This wasn’t tokenism—it was co-investigation.
đź“‹ In Guideline Panels
Before the Meeting:
- Ensure patient panelists reflect diversity in race, geography, disability, gender, and care experiences.
- Offer orientation and mentorship in guideline methodology.
- Provide stipends that reflect time and expertise.
During Deliberation:
- Translate technical content into plain, real-life terms.
- Facilitate a space where patients can challenge assumptions.
- Ask explicitly: “What would make this recommendation work or fail in your community?”
After Publication:
- Create patient- and clinician-facing versions of the guidelines.
- Release in multiple formats—text, video, webinar, and print.
- Fund trusted messengers—peer leaders, community navigators, or advocates—to share and explain them.
âś… Concrete Actions to Improve Engagement at All Levels
Here’s what each group can do—right now—to shift from tokenism to transformation.
🏥 Institutions & Sponsors
- Mandate patient involvement from the pre-grant stage through final reporting.
- Create standard engagement contracts and compensation models.
- Include dissemination plans for patients in proposal evaluation criteria.
- Develop training programs for both researchers and PWLE.
👨‍🔬 Researchers & Investigators
- Invite feedback from PWLE at every stage, not just the beginning.
- Hold exit interviews with patient advisors to learn and adapt.
- Publish joint reflections with PWLE on the engagement experience.
đź“‹ Guideline Development Organizations
- Share drafts with patient panels before public comment.
- Use deliberative democracy tools to surface lived experience concerns.
- Post how input changed recommendations—side-by-side comparison of draft vs. final.
đź“Ł PWLE & Patient Advocates
- Ask for co-authorship, not just acknowledgment.
- Push for roles on advisory boards, funding committees, and oversight panels.
- Demand accessible dissemination—and lead it where necessary.
🧰 Tools You Can Use Today
- PCORI Foundational Expectations for Partnerships in Research (2023):
https://www.pcori.org/engagement-research/engagement-resources/foundational-expectations
A current, comprehensive framework outlining six foundational expectations for meaningful engagement across all phases of research. - PCORI Archived Engagement Rubric (2014) (useful for operational structure examples):
https://www.pcori.org/sites/default/files/Engagement-Rubric.pdf - CDMRP Consumer Reviewer Training and Participation:
https://cdmrp.health.mil/cwg/default
For patients and advocates who wish to serve as peer reviewers for Congressionally Directed Medical Research Programs. - CIHR SPOR Patient Engagement Framework (Canada):
https://cihr-irsc.gc.ca/e/48413.html
A national model from Canada supporting inclusive, respectful, and sustainable patient engagement across health research systems.
🚨 Call to Action: Let’s Move from “Voice” to “Vote”
👨‍🔬 To Researchers, Clinicians, and Trial Sponsors:
Patient engagement is not charity work—it’s smart science and smart policy. Start co-designing with PWLE, co-own the outputs, and fund the relationship like you fund everything else. And don’t stop when the trial ends. Make engagement a deliverable, not an afterthought.
đź“Ł To PWLE Advocates and Patient Leaders:
Push beyond participation. Advocate for structural change. Ask where the power is—and claim it. You’re not just there to react to science. You’re there to help build it. Bring others with you.
If you’re doing this work—or want to—drop a comment or reach out. Let’s build alliances that actually make research and policy better for all of us.
📬 Contact: jtomn482171@gmail.com
💬 Comments open below. Let’s talk. Let’s act.